Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma
- PMID: 11454718
Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma
Abstract
Overexpression of E2F-1 induces apoptosis by both a p14ARF-p53- and a p73-mediated pathway. p14ARF is the alternate tumor suppressor product of the INK4a/ARF locus that is inactivated frequently in lung carcinogenesis. Because p14ARF stabilizes p53, it has been proposed that the loss of p14ARF is functionally equivalent to a p53 mutation. We have tested this hypothesis by examining the genomic status of the unique exon 1beta of p14ARF in 53 human cell lines and 86 primary non-small cell lung carcinomas and correlated this with previously characterized alterations of p53. Homozygous deletions of p14ARF were detected in 12 of 53 (23%) cell lines and 16 of 86 (19%) primary tumors. A single cell line, but no primary tumors, harbored an intragenic mutation. The deletion of p14ARF was inversely correlated with the loss of p53 in the majority of cell lines (P = 0.02), but this relationship was not maintained among primary tumors (P = 0.5). E2F-1 can also induce p73 via a p53-independent apoptotic pathway. Although we did not observe inactivation of p73 by either mutation or DNA methylation, haploinsufficiency of p73 correlated positively with either p14ARF or p53 mutation or both (P = 0.01) in primary non-small cell lung carcinomas. These data are consistent with the current model of p14ARF and p53 interaction as a complex network rather than a simple linear pathway and indicate a possible role for an E2F-1-mediated failsafe, p53-independent, apoptotic pathway involving p73 in human lung carcinogenesis.
Similar articles
-
The role of the transcription factor DP in apoptosis.Apoptosis. 2003 Oct;8(5):461-8. doi: 10.1023/a:1025586207239. Apoptosis. 2003. PMID: 12975577 Review.
-
From p63 to p53 across p73.FEBS Lett. 2001 Feb 16;490(3):163-70. doi: 10.1016/s0014-5793(01)02119-6. FEBS Lett. 2001. PMID: 11223031 Review.
-
Role of the p53-homologue p73 in E2F1-induced apoptosis.Nat Genet. 2000 Dec;26(4):464-9. doi: 10.1038/82617. Nat Genet. 2000. PMID: 11101847
-
Role for the p53 homologue p73 in E2F-1-induced apoptosis.Nature. 2000 Oct 5;407(6804):645-8. doi: 10.1038/35036614. Nature. 2000. PMID: 11034215
-
Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.Oncogene. 1999 Oct 21;18(43):5843-9. doi: 10.1038/sj.onc.1203003. Oncogene. 1999. PMID: 10557071
Cited by
-
Roles of ARF tumour suppressor protein in lung cancer: time to hit the nail on the head!Mol Cell Biochem. 2021 Mar;476(3):1365-1375. doi: 10.1007/s11010-020-03996-0. Epub 2021 Jan 3. Mol Cell Biochem. 2021. PMID: 33392921 Review.
-
Defined factors to reactivate cell cycle activity in adult mouse cardiomyocytes.Sci Rep. 2019 Dec 11;9(1):18830. doi: 10.1038/s41598-019-55027-8. Sci Rep. 2019. PMID: 31827131 Free PMC article.
-
Reviving the guardian of the genome: Small molecule activators of p53.Pharmacol Ther. 2017 Oct;178:92-108. doi: 10.1016/j.pharmthera.2017.03.013. Epub 2017 Mar 27. Pharmacol Ther. 2017. PMID: 28351719 Free PMC article. Review.
-
Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?Cell Death Dis. 2014 Aug 7;5(8):e1360. doi: 10.1038/cddis.2014.326. Cell Death Dis. 2014. PMID: 25101673 Free PMC article. Review.
-
ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma.Oncogene. 2014 May 15;33(20):2665-73. doi: 10.1038/onc.2013.208. Epub 2013 Jun 10. Oncogene. 2014. PMID: 23752194 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous